BRUNO, WILLIAM
 Distribuzione geografica
Continente #
EU - Europa 8.717
AS - Asia 1.024
NA - Nord America 1.018
Continente sconosciuto - Info sul continente non disponibili 215
SA - Sud America 89
AF - Africa 14
OC - Oceania 1
Totale 11.078
Nazione #
IT - Italia 8.511
US - Stati Uniti d'America 952
SG - Singapore 379
CN - Cina 233
VN - Vietnam 179
BD - Bangladesh 142
FR - Francia 71
BR - Brasile 52
FI - Finlandia 37
CA - Canada 32
DE - Germania 25
HK - Hong Kong 23
JP - Giappone 21
AR - Argentina 17
GB - Regno Unito 13
CH - Svizzera 11
NL - Olanda 11
IN - India 8
MX - Messico 8
IQ - Iraq 6
RU - Federazione Russa 6
CO - Colombia 5
ES - Italia 5
GT - Guatemala 5
HN - Honduras 5
JM - Giamaica 5
ID - Indonesia 4
LT - Lituania 4
PL - Polonia 4
SA - Arabia Saudita 4
AT - Austria 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
NI - Nicaragua 2
PE - Perù 2
PK - Pakistan 2
TR - Turchia 2
UA - Ucraina 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AG - Antigua e Barbuda 1
AU - Australia 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
IE - Irlanda 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MW - Malawi 1
NP - Nepal 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 10.863
Città #
Genova 4.074
Genoa 2.820
Rapallo 794
Vado Ligure 613
San Jose 213
Singapore 174
Ashburn 147
Council Bluffs 76
Lauterbourg 63
Hanoi 51
Beijing 50
Ho Chi Minh City 47
New York 39
Helsinki 34
Bordighera 27
Milan 26
Frankfurt am Main 21
Hong Kong 21
Los Angeles 19
Rome 17
Tokyo 15
Buffalo 13
Santa Clara 12
Houston 9
São Paulo 9
Atlanta 8
San Francisco 8
Zurich 8
Bologna 7
Chicago 7
Dallas 7
Haiphong 7
Montreal 7
Philadelphia 7
Phoenix 7
Tianjin 7
Louisville 6
Naples 6
Amsterdam 5
Boardman 5
Charlotte 5
Da Nang 5
London 5
Mexico City 5
Baghdad 4
Bari 4
Biên Hòa 4
Can Tho 4
Columbus 4
Detroit 4
Guatemala City 4
Land O' Lakes 4
Minneapolis 4
Monroe 4
Newark 4
Ocala 4
San Antonio 4
Toronto 4
Van Nuys 4
Vienna 4
Curitiba 3
Denver 3
Lake Worth 3
Lappeenranta 3
Las Vegas 3
Marseille 3
Miami 3
North Bergen 3
Prague 3
Rio de Janeiro 3
Riyadh 3
Rudolfstetten 3
San Pedro Sula 3
Warsaw 3
Addis Ababa 2
Albuquerque 2
Antioch 2
Asunción 2
Athens 2
Baku 2
Borgomanero 2
Boston 2
Brantford 2
Brooklyn 2
Brugherio 2
Brunswick 2
Buenos Aires 2
Bình Phước 2
Bắc Giang 2
Cagliari 2
Catania 2
Charleston 2
Chennai 2
Cincinnati 2
City of London 2
Clanton 2
Cleveland 2
Des Moines 2
Edmonton 2
Fort Lauderdale 2
Totale 9.664
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 260
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 246
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 242
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 233
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 222
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 221
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 220
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 219
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 219
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 218
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 214
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 210
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 209
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 202
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 200
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 197
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 192
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 189
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 187
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 180
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 177
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 177
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 176
Identification, genetic testing, and management of hereditary melanoma 173
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 168
A case of four synchronous cutaneous melanomas: Melanocortin 1 receptor polymorphisms and excessive sun exposure 166
Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure? 165
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 165
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 164
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 163
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 160
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 159
Current State of Target Treatment in BRAF Mutated Melanoma 159
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 158
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 157
Signs and genetics of rare cancer syndromes with gastroenterological features 157
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 157
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 155
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 155
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 148
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. 145
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 143
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 142
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 138
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 138
Novel MC1R variants in Ligurian melanoma patients and controls 135
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. 131
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations 131
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 130
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 128
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 127
Selection criteria for genetic assessment of patients with familial melanoma 123
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 117
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 115
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families 112
Novel MC1R variants and phenotypic expression of red hair in Ligurian melanoma patients and controls. 111
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy 107
Skin examination behavior: The role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination 105
Melanoma risk factors, perceived threat and intentional tanning: An international online survey 105
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 104
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 100
Multiple primary melanoma (MPM) as a valid criterion for genetic assessment : an Italian IMI multi-center study 93
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing 88
Predictors of sun protection behaviors and severe sunburn in an international online study 84
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 81
Molecular Assessment in Patients with Melanoma: When and Why? 77
Definitions of genetic testing in Italian legal documents 75
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 72
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 71
Seven Synchronous Primary Melanomas on the Back 70
A Glance at Molecular Advances in Cancer Genetics: A Baffling Puzzle Still to Be Solved 66
Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges 54
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomes 52
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer 50
Special Issue “Molecular Advances in Cancer Genetics 3.0” 19
Totale 11.078
Categoria #
all - tutte 37.326
article - articoli 35.431
book - libri 0
conference - conferenze 1.554
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 341
Totale 74.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 24 43 62 78 35 63 48 165 54 72 32 84
2022/2023960 103 78 11 100 195 115 3 72 149 5 115 14
2023/2024580 21 54 8 70 33 105 35 51 35 22 39 107
2024/20251.613 36 101 61 130 188 159 181 284 61 90 131 191
2025/20263.411 323 113 542 232 372 236 407 128 270 308 269 211
2026/2027270 270 0 0 0 0 0 0 0 0 0 0 0
Totale 11.078